Table 2. Antimicrobial susceptibilities of the evaluated species ( N  = 128) .

Antibiotics	Acinetobacter baumannii ( n  = 11)	Enterobacter aerogenes ( n  = 15)	Enterobacter cloacae ( n  = 7)	Escherichia coli ( n  = 27)	Klebsiella pneumoniae ( n  = 46)	Pseudomonas aeruginosa ( n  = 21)	Serratia marcescens ( n  = 1)	All isolates ( N  = 128)
Amikacin	5 (45.45%)	8 (53.33%)	6 (85.71%)	8 (29.63%)	20 (43.48%)	18 (85.71%)	1 (100.0%)	66 (51.56%)
Gentamicin	6 (54.54%)	8 (53.33%)	5 (71.43%)	16 (59.26%)	22 (47.83%)	18 (85.71%)	0 (0.0%)	75 (58.59%)
Tobramycin	6 (54.54%)	8 (53.33%)	5 (71.43%)	16 (59.26%)	23 (50.0%)	18 (85.71%)	0 (0.0%)	76 (59.38%)
Isepamicin	6 (54.54%)	8 (53.33%)	6 (85.71%)	18 (66.67%)	24 (52.17%)	18 (85.71%)	1 (100.0%)	81 (63.28%)